Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-7-8
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1546-170X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
712-3
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18607366-Animals, pubmed-meshheading:18607366-Blood-Brain Barrier, pubmed-meshheading:18607366-Brain, pubmed-meshheading:18607366-Brain Ischemia, pubmed-meshheading:18607366-Cerebral Arteries, pubmed-meshheading:18607366-Disease Models, Animal, pubmed-meshheading:18607366-Dose-Response Relationship, Drug, pubmed-meshheading:18607366-Humans, pubmed-meshheading:18607366-Lymphokines, pubmed-meshheading:18607366-Mice, pubmed-meshheading:18607366-Models, Biological, pubmed-meshheading:18607366-Piperazines, pubmed-meshheading:18607366-Platelet-Derived Growth Factor, pubmed-meshheading:18607366-Pyrimidines, pubmed-meshheading:18607366-Receptor, Platelet-Derived Growth Factor alpha, pubmed-meshheading:18607366-Signal Transduction, pubmed-meshheading:18607366-Stroke, pubmed-meshheading:18607366-Time Factors
pubmed:year
2008
pubmed:articleTitle
Imatinib buys time for brain after stroke.
pubmed:publicationType
Comment, News